Connect with us

CBD Industry

Study Shows Italians Prefer CBD (Cannabidiol) Over of Pharmaceuticals and Prescription Drugs

Ella H

Published

on

Study Shows Italians Prefer CBD (Cannabidiol) Over of Pharmaceuticals and Prescription Drugs

Italy’s government lawmakers have apparently legalized industrial hemp in 2016. As a result of legalization, thousands of businesses have began cultivating hemp, and others are enjoying the fruits of such labors. One interesting consequence that has been reported on increased CBD use is that Italians are now opting for CBD over pharmaceutical drugs.

A study released by EconPapers, titled Do-It-Yourself medicine? The impact of light cannabis liberalization on prescription drugs, studied the effects of “the unintended liberalization of light cannabis that took place in Italy in 2016 on prescription drugs sales.”

The study found that where the light cannabis became available, prescription drugs such as “opioids, anxiolytics, sedatives, anti-migraines, antiepileptics, anti-depressives and anti-psychotics” decreased. The researchers also stated in their analysis: “we find that the arrival of light cannabis in a given province led to a reduction in the number of dispensed boxes of anxiolytics by approximately 11.5%, reduction of dispensed sedatives by 10% and a reduction of dispensed anti-psychotics by 4.8%.”

In addition, the researchers pointed out that compared to other studies, the decrease in pharmaceutical use is not as pronounced here. Other studies have shown decreases of as much as 20%. One explanation for this may be the low threshold restrictions on THC in cannabis, which is 0.2%.

It also appears that state authorities have not responded well. A high court in Italy recently held that “derivatives” of cannabis – which includes smokable commodities like the low-THC flower – are illegal under the December 2016 law.

Ella D. Hughes’ input strengthens the legal presence at COR with her litigator nature and fondness with fitness and adamant cooking skills. During her undergraduate study, she dove deep into diverse fields of psychology, theater, evolutionary biology, psychopharmacology, and romance languages. After being admitted to the bar, COR is leaning on Ella to help cover the rapidly evolving cannabis and hemp industries for legal insights and regulatory law feedback.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Join Us On Facebook

Trending CBD News

TimesofCBD always fact checks sources and aims for the best accuracy in the reporting curated cannabis content consisting of the latest CBD news, user guides and product health research. Quality is the priority, but we are not eligible to be liable as everything here is for educational, informational purposes only. Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.

What Is CBD?

Copyright © 2019 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends: Telegram